Similar articles

• [Clinical aspects of liver cirrhosis, type B].

  Yamada G. Yamada G. Nihon Rinsho. 2004 Aug;62 Suppl 8:349-53. Nihon Rinsho. 2004. PMID: 15453344 Review. Japanese. No abstract available.
• Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.

  Lin CL, Kao JH. Lin CL, et al. J Biomed Sci. 2008 Mar;15(2):137-45. doi: 10.1007/s11373-007-9225-8. Epub 2007 Dec 5. J Biomed Sci. 2008. PMID: 18058038 Review.
• Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.

  Hui CK, Leung N, Shek WH, Zhang HY, Luk JM, Poon RT, Lo CM, Fan ST, Lau GK; Hong Kong Liver Fibrosis Study Group. Hui CK, et al. J Clin Gastroenterol. 2008 May-Jun;42(5):533-8. doi: 10.1097/MCG.0b013e31804bbdff. J Clin Gastroenterol. 2008. PMID: 18344885
• Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.

  Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS. Chen CH, et al. Gastroenterology. 2007 Nov;133(5):1466-74. doi: 10.1053/j.gastro.2007.09.002. Epub 2007 Sep 6. Gastroenterology. 2007. PMID: 17915220
• [Natural course and prognosis in asymptomatic carriers of hepatitis B virus].

  Suzuki K, Abe K, Kumagai I. Suzuki K, et al. Nihon Rinsho. 2004 Aug;62 Suppl 8:227-32. Nihon Rinsho. 2004. PMID: 15453320 Review. Japanese. No abstract available.